577.90
price down icon0.48%   -2.80
after-market Handel nachbörslich: 575.29 -2.61 -0.45%
loading
Schlusskurs vom Vortag:
$580.70
Offen:
$580.54
24-Stunden-Volumen:
1.02M
Relative Volume:
0.88
Marktkapitalisierung:
$60.20B
Einnahmen:
$14.21B
Nettoeinkommen (Verlust:
$4.46B
KGV:
14.56
EPS:
39.68
Netto-Cashflow:
$3.56B
1W Leistung:
-1.66%
1M Leistung:
+3.41%
6M Leistung:
-17.29%
1J Leistung:
-51.22%
1-Tages-Spanne:
Value
$570.35
$585.49
1-Wochen-Bereich:
Value
$570.35
$597.02
52-Wochen-Spanne:
Value
$476.49
$1,192.54

Regeneron Pharmaceuticals Inc Stock (REGN) Company Profile

Name
Firmenname
Regeneron Pharmaceuticals Inc
Name
Telefon
(914) 847-7000
Name
Adresse
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
Name
Mitarbeiter
15,207
Name
Twitter
@regeneron
Name
Nächster Verdiensttermin
2025-08-01
Name
Neueste SEC-Einreichungen
Name
REGN's Discussions on Twitter

Vergleichen Sie REGN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.90 61.55B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
401.00 100.25B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
447.00 58.53B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
706.41 43.59B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
332.04 33.67B 3.81B -644.79M -669.77M -6.24

Regeneron Pharmaceuticals Inc Stock (REGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-14 Eingeleitet Rothschild & Co Redburn Buy
2025-06-30 Herabstufung Argus Buy → Hold
2025-05-30 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2025-05-30 Herabstufung Wells Fargo Overweight → Equal Weight
2025-05-14 Hochstufung Citigroup Neutral → Buy
2025-04-22 Fortgesetzt Cantor Fitzgerald Overweight
2025-02-05 Hochstufung Leerink Partners Market Perform → Outperform
2025-01-16 Herabstufung UBS Buy → Neutral
2024-12-10 Fortgesetzt BofA Securities Underperform
2024-11-15 Eingeleitet Wolfe Research Outperform
2024-11-14 Eingeleitet Citigroup Neutral
2024-09-24 Herabstufung Leerink Partners Outperform → Market Perform
2024-03-12 Eingeleitet Bernstein Outperform
2024-01-12 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2023-11-09 Eingeleitet Deutsche Bank Hold
2023-11-03 Hochstufung Raymond James Mkt Perform → Outperform
2023-08-21 Hochstufung Canaccord Genuity Hold → Buy
2023-08-21 Bestätigt Oppenheimer Perform
2023-06-28 Herabstufung Canaccord Genuity Buy → Hold
2023-03-27 Hochstufung SVB Securities Market Perform → Outperform
2023-03-24 Hochstufung Jefferies Hold → Buy
2023-03-23 Hochstufung Raymond James Underperform → Mkt Perform
2023-01-30 Hochstufung Cowen Market Perform → Outperform
2023-01-20 Hochstufung JP Morgan Neutral → Overweight
2022-10-26 Herabstufung Raymond James Mkt Perform → Underperform
2022-10-17 Herabstufung Evercore ISI Outperform → In-line
2022-09-09 Hochstufung Jefferies Underperform → Hold
2022-09-09 Hochstufung Morgan Stanley Equal-Weight → Overweight
2022-07-25 Herabstufung SVB Leerink Outperform → Mkt Perform
2022-07-13 Eingeleitet Cantor Fitzgerald Neutral
2022-06-06 Eingeleitet Jefferies Underperform
2022-05-23 Eingeleitet SVB Leerink Outperform
2022-01-05 Herabstufung BofA Securities Neutral → Underperform
2022-01-03 Hochstufung Bernstein Mkt Perform → Outperform
2021-12-15 Herabstufung Bernstein Outperform → Mkt Perform
2021-12-09 Fortgesetzt Wells Fargo Overweight
2021-12-07 Fortgesetzt Cowen Market Perform
2021-12-06 Eingeleitet Goldman Buy
2021-11-19 Fortgesetzt BMO Capital Markets Outperform
2021-11-05 Herabstufung The Benchmark Company Buy → Hold
2021-06-29 Eingeleitet H.C. Wainwright Buy
2021-01-25 Hochstufung BMO Capital Markets Market Perform → Outperform
2021-01-13 Hochstufung The Benchmark Company Hold → Buy
2021-01-08 Hochstufung Citigroup Neutral → Buy
2020-10-05 Hochstufung Cantor Fitzgerald Neutral → Overweight
2020-08-20 Herabstufung The Benchmark Company Buy → Hold
2020-07-09 Hochstufung SunTrust Hold → Buy
2020-05-26 Hochstufung Wells Fargo Equal Weight → Overweight
2020-04-28 Herabstufung Citigroup Buy → Neutral
2020-04-17 Hochstufung The Benchmark Company Hold → Buy
2020-04-08 Eingeleitet The Benchmark Company Hold
2020-03-31 Eingeleitet Wolfe Research Peer Perform
2020-02-27 Eingeleitet Barclays Overweight
2020-02-26 Hochstufung Canaccord Genuity Hold → Buy
2020-02-26 Herabstufung Robert W. Baird Outperform → Neutral
2020-02-25 Hochstufung Jefferies Hold → Buy
2020-02-11 Hochstufung Argus Hold → Buy
2019-12-24 Eingeleitet Raymond James Mkt Perform
2019-12-16 Herabstufung Evercore ISI Outperform → In-line
2019-12-13 Hochstufung Credit Suisse Neutral → Outperform
2019-11-12 Eingeleitet SunTrust Hold
2019-11-07 Hochstufung Citigroup Neutral → Buy
2019-10-17 Fortgesetzt BofA/Merrill Neutral
2019-09-23 Hochstufung Guggenheim Neutral → Buy
Alle ansehen

Regeneron Pharmaceuticals Inc Aktie (REGN) Neueste Nachrichten

pulisher
12:19 PM

OMERS ADMINISTRATION Corp Sells 639 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

12:19 PM
pulisher
Sep 02, 2025

Landscape Capital Management L.L.C. Takes $1.03 Million Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Sep 02, 2025
pulisher
Sep 02, 2025

What are Regeneron Pharmaceuticals Inc.’s recent SEC filings showingJuly 2025 Pullbacks & Fast Gain Swing Trade Alerts - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Regeneron: Drug Pricing Woes Notwithstanding, Due For A Major Comeback (NASDAQ:REGN) - Seeking Alpha

Sep 02, 2025
pulisher
Sep 02, 2025

Wellington Management Group LLP Cuts Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Sep 02, 2025
pulisher
Sep 02, 2025

Kestra Advisory Services LLC Reduces Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Sep 02, 2025
pulisher
Sep 02, 2025

Lansforsakringar Fondforvaltning AB publ Reduces Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Sep 02, 2025
pulisher
Sep 02, 2025

Tema Etfs LLC Has $2.73 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Sep 02, 2025
pulisher
Sep 02, 2025

Evercore ISI Maintains a Buy on Regeneron Pharmaceuticals (REGN) With a $750 PT - Yahoo Finance

Sep 02, 2025
pulisher
Sep 02, 2025

Intraday pattern recognizer results for Regeneron Pharmaceuticals Inc.Stock Surge & Free High Accuracy Swing Entry Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

COPD Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma - Barchart.com

Sep 02, 2025
pulisher
Sep 02, 2025

Armistice Capital LLC Has $72.35 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Sep 02, 2025
pulisher
Sep 02, 2025

What the charts say about Regeneron Pharmaceuticals Inc. todayStock Surge & Long-Term Safe Investment Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What makes Regeneron Pharmaceuticals Inc. stock price move sharplyPortfolio Value Report & Free Weekly Watchlist of Top Performers - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Orion Investment Co Boosts Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Sep 02, 2025
pulisher
Sep 02, 2025

Guggenheim Capital LLC Sells 4,547 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Sep 02, 2025
pulisher
Sep 02, 2025

Real time alert setup for Regeneron Pharmaceuticals Inc. performanceWeekly Loss Report & Reliable Entry Point Trade Alerts - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

What is Regeneron Pharmaceuticals Inc. s 5 year growth outlookWeekly Investment Recap & Expert Approved Trade Ideas - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $781.00 - MarketBeat

Sep 01, 2025
pulisher
Sep 01, 2025

Regeneron Pharmaceuticals, Inc. $REGN Holdings Increased by Comerica Bank - MarketBeat

Sep 01, 2025
pulisher
Sep 01, 2025

Regeneron Pharmaceuticals Inc. stock trend forecastWeekly Investment Report & Free Growth Oriented Trading Recommendations - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Analyzing Regeneron Pharmaceuticals Inc. with multi timeframe charts2025 Top Decliners & Expert Approved Trade Ideas - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Will Regeneron Pharmaceuticals Inc. stock recover after earnings2025 Key Highlights & Expert Verified Movement Alerts - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Canada Pension Plan Investment Board Trims Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Sep 01, 2025
pulisher
Sep 01, 2025

Ieq Capital LLC Has $5.21 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Sep 01, 2025
pulisher
Sep 01, 2025

Tools to assess Regeneron Pharmaceuticals Inc.’s risk profileLayoff News & Free Weekly Chart Analysis and Trade Guides - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

How to contact the Daily Bulletin - FinancialContent

Sep 01, 2025
pulisher
Sep 01, 2025

Key resistance and support levels for Regeneron Pharmaceuticals IncJuly 2025 Spike Watch & Reliable Price Breakout Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Harvest Portfolios Group Inc. Acquires 11,555 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Sep 01, 2025
pulisher
Sep 01, 2025

CW Advisors LLC Purchases Shares of 1,428 Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Sep 01, 2025
pulisher
Aug 31, 2025

Kayne Anderson Rudnick Investment Management LLC Buys 3,288 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 31, 2025
pulisher
Aug 31, 2025

Regeneron Pharmaceuticals Inc. stock trend outlook and recovery pathWeekly Profit Analysis & Breakout Confirmation Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Rafferty Asset Management LLC Trims Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 31, 2025
pulisher
Aug 31, 2025

What candlestick patterns are forming on Regeneron Pharmaceuticals Inc.Jobs Report & Expert Curated Trade Setups - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

1832 Asset Management L.P. Has $1.33 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 31, 2025
pulisher
Aug 31, 2025

Regeneron Pharmaceuticals Inc. stock prediction for this weekQuarterly Growth Report & AI Driven Stock Reports - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Ceredex Value Advisors LLC Buys New Shares in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 31, 2025
pulisher
Aug 31, 2025

Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Corebridge Financial Inc. - MarketBeat

Aug 31, 2025
pulisher
Aug 31, 2025

FORA Capital LLC Has $3.46 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 31, 2025
pulisher
Aug 31, 2025

What to expect from Regeneron Pharmaceuticals Inc. in the next 30 days2025 Performance Recap & Entry Point Strategy Guides - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Key resistance and support levels for Regeneron Pharmaceuticals Inc.Market Activity Report & Daily Profit Focused Stock Screening - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Algert Global LLC Takes $288,000 Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 31, 2025
pulisher
Aug 31, 2025

Epoch Investment Partners Inc. Has $131.58 Million Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 31, 2025
pulisher
Aug 31, 2025

How to track smart money flows in Regeneron Pharmaceuticals Inc.July 2025 Decliners & Consistent Growth Equity Picks - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Price Reversal in Regeneron Pharmaceuticals Inc. Traders Watch Closely getLinesFromResByArray error: size == 0 - thegnnews.com

Aug 31, 2025
pulisher
Aug 31, 2025

The Manufacturers Life Insurance Company Has $252.57 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 31, 2025
pulisher
Aug 31, 2025

Magnetar Financial LLC Has $7.32 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 31, 2025
pulisher
Aug 31, 2025

Te Ahumairangi Investment Management Ltd Purchases New Shares in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 31, 2025
pulisher
Aug 31, 2025

Published on: 2025-08-31 02:13:11 - Newser

Aug 31, 2025

Finanzdaten der Regeneron Pharmaceuticals Inc-Aktie (REGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$447.00
price up icon 0.11%
$706.41
price down icon 0.81%
biotechnology ONC
$332.04
price up icon 8.49%
$145.30
price up icon 6.76%
$100.62
price up icon 0.62%
Kapitalisierung:     |  Volumen (24h):